Distribution of late phase oncology pipeline 2008 vs. 2018 by type
This statistic shows the distribution of late phase oncology pipeline in 2008 and 2018, by type. In 2008, some 55 percent of all late stage oncology products included in the pipeline were targeted small molecule therapies. This share decreased to around 40 percent ten years later.
